Unknown

Dataset Information

0

Controlled and tuneable drug release from electrospun fibers and a non-invasive approach for cytotoxicity testing.


ABSTRACT: Electrospinning is an attractive method to generate drug releasing systems. In this work, we encapsulated the cell death-inducing drug Diclofenac (DCF) in an electrospun poly-L-lactide (PLA) scaffold. The scaffold offers a system for a sustained and controlled delivery of the cytotoxic DCF over time making it clinically favourable by achieving a prolonged therapeutic effect. We exposed human dermal fibroblasts (HDFs) to the drug-eluting scaffold and employed multiphoton microscopy and fluorescence lifetime imaging microscopy. These methods were suitable for non-invasive and marker-independent assessment of the cytotoxic effects. Released DCF induced changes in cell morphology and glycolytic activity. Furthermore, we showed that drug release can be influenced by adding dimethyl sulfoxide as a co-solvent for electrospinning. Interestingly, without affecting the drug diffusion mechanism, the resulting PLA scaffolds showed altered fibre morphology and enhanced initial DCF burst release. The here described model could represent an interesting way to control the diffusion of encapsulated bio-active molecules and test them using a marker-independent, non-invasive approach.

SUBMITTER: Piccirillo G 

PROVIDER: S-EPMC6401126 | biostudies-literature | 2019 Mar

REPOSITORIES: biostudies-literature

altmetric image

Publications

Controlled and tuneable drug release from electrospun fibers and a non-invasive approach for cytotoxicity testing.

Piccirillo G G   Carvajal Berrio D A DA   Laurita A A   Pepe A A   Bochicchio B B   Schenke-Layland K K   Hinderer S S  

Scientific reports 20190305 1


Electrospinning is an attractive method to generate drug releasing systems. In this work, we encapsulated the cell death-inducing drug Diclofenac (DCF) in an electrospun poly-L-lactide (PLA) scaffold. The scaffold offers a system for a sustained and controlled delivery of the cytotoxic DCF over time making it clinically favourable by achieving a prolonged therapeutic effect. We exposed human dermal fibroblasts (HDFs) to the drug-eluting scaffold and employed multiphoton microscopy and fluorescen  ...[more]

Similar Datasets

| S-EPMC5708548 | biostudies-literature
| S-EPMC8839822 | biostudies-literature
| S-EPMC10386385 | biostudies-literature
| S-EPMC6461716 | biostudies-literature
| S-EPMC6660177 | biostudies-literature
| S-EPMC8537833 | biostudies-literature
| S-EPMC7164776 | biostudies-literature
| S-EPMC8308421 | biostudies-literature
| S-EPMC5654553 | biostudies-literature
| S-EPMC3267001 | biostudies-literature